Literature DB >> 18308219

Preoperative radiographic assessment of hepatic steatosis with histologic correlation.

Clifford S Cho1, Sean Curran, Lawrence H Schwartz, David A Kooby, David S Klimstra, Jinru Shia, Alejandro Munoz, Yuman Fong, William R Jarnagin, Ronald P DeMatteo, Leslie H Blumgart, Michael I D'Angelica.   

Abstract

BACKGROUND: The adverse impact of hepatic steatosis on perioperative outcomes after liver resection is gaining recognition. But the accuracy of preoperative radiologic assessment of fatty liver disease remains unclear. The objective of this study was to correlate preoperative radiologic estimation with postoperative histologic measurement of steatosis. STUDY
DESIGN: Patients who underwent partial hepatectomy between 1997 and 2001, with complete preoperative radiographic imaging and postoperative pathologic assessment of steatosis, were retrospectively analyzed. The presence of steatosis was assessed radiographically using noncontrast-enhanced CT (NCCT), contrast-enhanced CT (CCT), or MRI, using standard quantitative radiologic criteria. Repeat histologic analysis was used to quantify the extent of hepatic steatosis.
RESULTS: One hundred thirty-one patients were studied. The overall sensitivity and specificity for all imaging modalities in detecting pathologically confirmed hepatic steatosis were 56% and 82%, respectively. Sensitivity and specificity for NCCT, CCT, and MRI using standard quantitative criteria were 33% and 100%, 50% and 83%, and 88%, and 63%, respectively. Increasing body mass indices adversely affected the accuracy of NCCT (p=0.002). Preoperative chemotherapy did not notably affect radiologic accuracy.
CONCLUSIONS: The presence of a fatty-appearing liver on NCCT scans indicates clinically significant steatosis, but steatosis cannot be excluded based on a normal NCCT scan, particularly in obese patients. Conversely, normal MRI helps to exclude hepatic steatosis, but abnormal MRI is not a reliable indicator of fatty change. CCT is not an effective means of identifying steatosis. We conclude that, when used alone, conventional cross-sectional imaging does not consistently permit accurate identification of hepatic steatosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18308219     DOI: 10.1016/j.jamcollsurg.2007.08.020

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  13 in total

1.  The utility of Xenon-133 liver scan in the diagnosis and management of nonalcoholic fatty liver disease.

Authors:  Said A Al-Busafi; Peter Ghali; Philip Wong; Javier A Novales-Diaz; Marc Deschênes
Journal:  Can J Gastroenterol       Date:  2012-03       Impact factor: 3.522

2.  Diagnosis value of focal liver lesions with SonoVue®-enhanced ultrasound compared with contrast-enhanced computed tomography and contrast-enhanced MRI: a meta-analysis.

Authors:  Yang Guang; LiMei Xie; Hailong Ding; AiLu Cai; Ying Huang
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-18       Impact factor: 4.553

3.  3.0T ¹H magnetic resonance spectroscopy for assessment of steatosis in patients with chronic hepatitis C.

Authors:  Qian Zhang; Hui-Mao Zhang; Wen-Qian Qi; Yong-Gui Zhang; Ping Zhao; Jian Jiao; Jiang-Bin Wang; Chun-Yu Zhang
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

4.  Advances in therapeutics for liver metastasis from colorectal cancer.

Authors:  Akira Kobayashi; Shinichi Miyagawa
Journal:  World J Gastrointest Oncol       Date:  2010-10-15

Review 5.  Metabolic syndrome and hepatic resection: improving outcome.

Authors:  Shefali Agrawal; Cherag Daruwala
Journal:  HPB (Oxford)       Date:  2011-10-19       Impact factor: 3.647

6.  Fatty liver disease is associated with underlying cardiovascular disease in HIV-infected persons(*).

Authors:  Nf Crum-Cianflone; D Krause; D Wessman; S Medina; J Stepenosky; C Brandt; G Boswell
Journal:  HIV Med       Date:  2011-01-20       Impact factor: 3.180

7.  The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis.

Authors:  Anneloes E Bohte; Jochem R van Werven; Shandra Bipat; Jaap Stoker
Journal:  Eur Radiol       Date:  2010-07-31       Impact factor: 5.315

8.  Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.

Authors:  Takeshi Yokoo; Mark Bydder; Gavin Hamilton; Michael S Middleton; Anthony C Gamst; Tanya Wolfson; Tarek Hassanein; Heather M Patton; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2009-02-12       Impact factor: 11.105

9.  MRI liver fat quantification in an oncologic population: the added value of complex chemical shift-encoded MRI.

Authors:  Giuseppe Corrias; Simone Krebs; Sarah Eskreis-Winkler; Davinia Ryan; Junting Zheng; Marinela Capanu; Luca Saba; Serena Monti; Maggie Fung; Scott Reeder; Lorenzo Mannelli
Journal:  Clin Imaging       Date:  2018-08-08       Impact factor: 1.605

10.  Diagnostic performance of a rapid magnetic resonance imaging method of measuring hepatic steatosis.

Authors:  Michael J House; Eng K Gan; Leon A Adams; Oyekoya T Ayonrinde; Sander J Bangma; Prithi S Bhathal; John K Olynyk; Tim G St Pierre
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.